WHAT'S NEW
Things Are Happening at MORSE!
Season’s Greetings from MORSE Consulting 2022
Happy Holidays from MORSE Consulting! As we enter the festive season and close our sixth year of operations, we express our heartfelt gratitude to the pharmaceutical market access community, including our clients, strategic partners, and team members. We wish you all a safe, peaceful, and enjoyable holiday season and the best for 2023!! —
MORSE Consulting Adds Pharmacoeconomic and Innovative Agreement Expertise
Toronto, September 7, 2022 – MORSE Consulting is delighted to announce the addition of 2 new team members, Jaclyn Beca and Sang Mi Lee who will enhance MORSE’s reimbursement expertise into pharmacoeconomics, generation and use of real world evidence (RWE) and development of innovative agreements. We are at an exciting time in drug discovery and research as new technologies, such as cell and gene…
Season’s Greetings from MORSE Consulting
Wishing you Season’s Greetings from MORSE Consulting! As we enter the holiday season and close our fifth year of operations, we would like to express our appreciation and gratitude to the pharmaceutical market access community, including our clients, strategic partners, and team members. We wish you all a safe, healthy, and enjoyable holiday break and the very best for 2022! Happy Holidays, …
MORSE Strengthens Public Payer Expertise
Toronto, September 7, 2021 – MORSE Consulting is pleased to announce the addition of Katherine Scott as a Consultant. The Canadian public system remains one of the critical payers in this country’s pharmaceutical reimbursement pathway. This system is growing increasingly complex with new funding mechanisms for emerging gene and cell therapies, novel approaches related to outcomes-based agreements, evolving policies related to biosimilars, and variations…
MORSE Consulting Releases 2021 Edition of the Canadian Reimbursement and Forecasting Timelines Report
Toronto, May 4th, 2021 – MORSE Consulting is pleased to release their 2021 edition of the Canadian Reimbursement and Forecasting Timelines (CRaFT) report - a comprehensive source of reimbursement timelines and insights to inform forecasting and planning needs. MORSE has analyzed Canadian market access data from 2018 through 2020 to produce key reimbursement metrics. The report will support forecasting or planning necessary for launch in…
Season’s Greetings from MORSE Consulting
Happy Holidays from MORSE Consulting! As we enter the holiday season and the close of our fourth year of MORSE’s operations, we wish to share our gratitude to our community – our clients, strategic partners, and team members, for banding together and supporting each other through a challenging year. —
MORSE Consulting Bolsters Private Payer Expertise
Toronto, September 9, 2020 – MORSE Consulting is pleased to announce that Sal Cimino has joined our team as Senior Consultant, Private Drug Plans. The private payer market is playing an increasingly important role in ensuring a product’s reimbursement success in Canada. With the introduction of new specialty biologics and gene therapies, private payers are turning to new cost containment strategies that strongly resemble…
April 2020 Update to The Canadian Reimbursement Trends & Timelines Report – Now Available
Toronto, April 27, 2020 – MORSE Consulting is pleased to release our April 2020 Update to the Canadian Reimbursement Trends and Timelines report – a comprehensive, credible and relevant source of market access intelligence. This 50+ PowerPoint report is aimed at assisting market access professionals plan for future launches and also serves as a valuable education tool for both internal and external stakeholders. What’s…
MORSE Consulting Strengthens HTA Strategy and Payer Expertise
Toronto, February 18, 2020 – MORSE Consulting is pleased to expand and strengthen our service offering with the addition of Anita Carrie and Roy Cairns. Affordability of effective and innovative medications within the current Canadian public funding model is becoming very challenging for the healthcare system. Increasing budgetary constraints coupled with complex treatments requiring consideration of different sources and levels of evidence are an…
Season’s Greetings from MORSE Consulting
Happy Holidays from MORSE Consulting! As we enter the holiday season and the close of MORSE’s third year of operation, we wish to express our heartfelt gratitude to the Pharmaceutical Market Access community. We wish you a safe, peaceful, and enjoyable holiday season and the very best for 2020! —
NEW Canadian Reimbursement Trends and Timelines Report – now available!
Toronto, September 18, 2019 – MORSE Consulting is pleased to launch the Canadian Reimbursement Trends and Timelines report – a  comprehensive, credible and relevant source of market access intelligence. The market access pathway in Canada is going through an unprecedented level of change and uncertainty. This 58-page PowerPoint report is aimed at not only helping market access professionals plan for future launches but can…
Season’s Greetings from MORSE Consulting
We wish you a safe, peaceful, and enjoyable holiday season and the very best for 2019. —
Anita Gadhok Strengthens MORSE Consulting’s Payer Expertise
Toronto, October 9, 2018 –MORSE Consulting is pleased to announce the addition of Anita Gadhok as Senior Consultant. With more than 20 years of experience, Anita has worked with provincial drug programs, cancer agencies, private insurance, and community pharmacies in both Ontario and Manitoba. She has been involved in a number of ground-breaking initiatives including precursor work to support the development of the pan-Canadian…
MORSE Consulting Proudly Participates at the 2018 CADTH Symposium
MORSE Consulting’s Managing Principal, Sherry O’Quinn, and Principal Consultant, Brad Alyward, are proud to participate in this year’s CADTH Symposium taking place from April 15-17, 2018 in Halifax, Nova Scotia. Further details on MORSE, and its strategic partner’s (Cornerstone Research Group) participation can be found below. April 16, 2018 15:15-16:30 ADT Sherry O’Quinn moderates a panel on oncology drugs with Alex Chambers…
Cornerstone Research Group and MORSE Consulting form a Strategic Partnership
Toronto, February 7, 2018: Cornerstone Research Group and MORSE Consulting are pleased to announce the creation of a strategic partnership between our two organizations. This strategic partnership will simplify the logistical process for our clients utilizing our combined services when shepherding a product from reimbursement strategy, to CADTH submission and finally to pCPA negotiations. Together the collaboration between Cornerstone and MORSE offers clients…
MORSE Consulting Inc. | Deciphering Canadian pharmaceutical market access signals to create reimbursement success.
© 2022 MORSE Consulting Inc. All rights reserved. |
Site by Directica Media
What's New